News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,423 Results
Type
Article (86479)
Company Profile (702)
Press Release (759242)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232674)
Career Advice (4127)
Deals (39719)
Drug Delivery (129)
Drug Development (90982)
Employer Resources (198)
FDA (18106)
Job Trends (17333)
News (396449)
Policy (39746)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56831)
ALS (99)
Alzheimer's disease (1503)
Antibody-drug conjugate (ADC) (157)
Approvals (18068)
Artificial intelligence (329)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (304)
Cancer (2450)
Cardiovascular disease (206)
Career advice (3534)
Career pathing (34)
CAR-T (174)
Cell therapy (494)
Cervical cancer (21)
Clinical research (73407)
Collaboration (915)
Company closure (1)
Compensation (567)
Complete response letters (30)
COVID-19 (2868)
CRISPR (48)
C-suite (266)
Cystic fibrosis (107)
Data (2284)
Decentralized trials (2)
Denatured (45)
Depression (56)
Diabetes (299)
Diagnostics (6922)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (128)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96692)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130047)
Executive appointments (779)
FDA (19453)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (819)
Gene editing (120)
Generative AI (35)
Gene therapy (359)
GLP-1 (855)
Government (5160)
Grass and pollen (6)
Guidances (75)
Healthcare (20886)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (148)
Indications (30)
Infectious disease (3029)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (812)
IPO (17816)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (558)
Leadership (24)
Legal (10113)
Liver cancer (82)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (354)
MASH (76)
Medical device (14639)
Medtech (14644)
Mergers & acquisitions (22445)
Metabolic disorders (793)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (2110)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (40)
Obesity (426)
Opinion (275)
Ovarian cancer (79)
Pain (99)
Pancreatic cancer (88)
Parkinson's disease (161)
Partnered (24)
Patents (251)
Patient recruitment (116)
Peanut (51)
People (65304)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22655)
Phase II (31867)
Phase III (24016)
Pipeline (1264)
Policy (173)
Postmarket research (3552)
Preclinical (10222)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (430)
Real estate (7392)
Recruiting (75)
Regulatory (26802)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (91)
Service/supplier (30)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (46)
The Weekly (82)
Vaccines (815)
Venture capitalists (44)
Weight loss (305)
Women's health (40)
Worklife (20)
Date
Today (116)
Last 7 days (973)
Last 30 days (2777)
Last 365 days (35782)
2025 (11962)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (50135)
Australia (8830)
California (6475)
Canada (2073)
China (564)
Colorado (284)
Connecticut (303)
Delaware (160)
Europe (114992)
Florida (946)
Georgia (221)
Hawaii (1)
Idaho (64)
Illinois (632)
India (31)
Indiana (335)
Iowa (12)
Japan (171)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (972)
Massachusetts (4962)
Michigan (248)
Minnesota (423)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (70)
New Jersey (1832)
New Mexico (31)
New York (1839)
North Carolina (1133)
North Dakota (9)
Northern California (2764)
Ohio (220)
Oklahoma (15)
Oregon (48)
Pennsylvania (1426)
Puerto Rico (13)
Rhode Island (36)
South America (1652)
South Carolina (24)
South Dakota (1)
Southern California (2402)
Tennessee (105)
Texas (973)
United States (24884)
Utah (193)
Virginia (172)
Washington D.C. (70)
Washington State (607)
West Virginia (3)
Wisconsin (70)
There are 846,423 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genezen and Optieum Biotechnologies Partner to Support cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma
May 5, 2025
·
3 min read
Press Releases
Scribe Therapeutics to Highlight In Vivo CRISPR-based Genome Editing Data for Duchenne Muscular Dystrophy at ASGCT 2025, in Addition to Joint Presentation with Prevail Therapeutics, a Part of Lilly’s Gene Therapy Division
May 5, 2025
·
3 min read
Press Releases
Elemental Machines Announces Leadership Transition: Rob Estrella Promoted to CEO
May 5, 2025
·
2 min read
Press Releases
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
May 5, 2025
·
2 min read
Press Releases
Ferring Presents New Phase 3b Safety and Effectiveness Data for Recurrent C. Diff Patients Receiving REBYOTA® (fecal microbiota, live – jslm) Via Colonoscopy, and Additional Analyses at DDW
May 5, 2025
·
9 min read
Press Releases
Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis
May 5, 2025
·
6 min read
Press Releases
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume
May 5, 2025
·
10 min read
Press Releases
Chemomab Announces Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis in Distinguished Plenary Session at DDW 2025
May 5, 2025
·
8 min read
Press Releases
Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025
May 5, 2025
·
1 min read
Press Releases
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
May 5, 2025
·
5 min read
1 of 84,643
Next
